Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000707511-09-000003
Filing Date
2009-10-26
Accepted
2009-10-26 14:28:46
Documents
1
Effectiveness Date
2009-10-26
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10022
  Complete submission text file 0000707511-09-000003.txt   11682
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-70751-1P | Film No.: 091136600
SIC: 2834 Pharmaceutical Preparations